当前位置:首页 - 行情中心 - 步长制药(603858) - 财务分析 - 现金流量表

步长制药

(603858)

  

流通市值:182.50亿  总市值:182.50亿
流通股本:11.06亿   总股本:11.06亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,929,463,148.1211,706,028,235.718,577,455,854.545,773,523,040.41
收到的税费返还-3,522,821.592,904,603.312,638,821.09
收到其他与经营活动有关的现金63,143,319.6846,748,050.14203,174,384.8476,701,732.3
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,992,606,467.811,756,299,107.448,783,534,842.695,852,863,593.8
购买商品、接受劳务支付的现金526,854,643.762,860,282,382.531,969,430,996.011,336,272,705.91
支付给职工以及为职工支付的现金241,722,628.451,033,775,872.62792,342,148.57520,553,351.77
支付的各项税费364,147,684.171,422,258,079.791,050,616,577.62742,587,912
支付其他与经营活动有关的现金1,181,865,196.615,500,032,203.574,269,681,091.192,756,249,543.28
经营活动现金流出的平衡项目00.0100
经营活动现金流出小计2,314,590,152.9910,816,348,538.528,082,070,813.395,355,663,512.96
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额678,016,314.81939,950,568.92701,464,029.3497,200,080.84
二、投资活动产生的现金流量:
取得投资收益收到的现金1,251,052.812,969,310.322,430,468.65-
处置固定资产、无形资产和其他长期资产收回的现金净额92,355491,704.83403,605.1540,860
收到的其他与投资活动有关的现金1,546,364.967,535,769.775,308,128.253,580,608.75
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,889,772.7710,996,784.928,142,202.053,621,468.75
购建固定资产、无形资产和其他长期资产支付的现金37,477,008.39196,995,309.52188,978,477.05134,148,285.08
投资支付的现金302,200,00063,550,00013,750,00013,750,000
支付其他与投资活动有关的现金-3,002.36--
投资活动现金流出的平衡项目0000
投资活动现金流出小计339,677,008.39260,548,311.88202,728,477.05147,898,285.08
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-336,787,235.62-249,551,526.96-194,586,275-144,276,816.33
三、筹资活动产生的现金流量:
吸收投资收到的现金1,366,66620,890,00020,790,0006,790,000
其中:子公司吸收少数股东投资收到的现金1,366,66620,890,00020,790,0006,790,000
取得借款收到的现金624,000,0002,306,170,243.31,951,570,243.31,496,960,243.3
收到其他与筹资活动有关的现金58,028,436.721,877,453.13952,251.05954,661.49
筹资活动现金流入平衡项目0000
筹资活动现金流入小计683,395,102.722,328,937,696.431,973,312,494.351,504,704,904.79
偿还债务支付的现金309,976,632.621,806,833,413.451,296,792,211.08767,308,244.86
分配股利、利润或偿付利息支付的现金29,779,651.85287,180,976.8252,673,485.4169,190,569.75
其中:子公司支付给少数股东的股利、利润-14,744,765.2813,654,028.78-
支付其他与筹资活动有关的现金71,572,881.08800,133,181.83665,751,173.41452,716,250.08
筹资活动现金流出平衡项目0000
筹资活动现金流出小计411,329,165.552,894,147,572.082,215,216,869.91,289,215,064.69
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额272,065,937.17-565,209,875.65-241,904,375.55215,489,840.1
四、汇率变动对现金及现金等价物的影响-42,158.2310,649.55-2,404.554,576.66
现金及现金等价物净增加额平衡项目00.0100
五、现金及现金等价物净增加额613,252,858.13125,199,815.87264,970,974.2568,417,681.27
加:期初现金及现金等价物余额817,532,973.76692,333,157.89692,333,157.89692,333,157.89
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,430,785,831.89817,532,973.76957,304,132.091,260,750,839.16
补充资料:
净利润--702,394,653.25-181,135,199.55
资产减值准备-977,512,390.37-22,290,970.42
固定资产和投资性房地产折旧-403,681,531.89-200,246,018.09
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-403,681,531.89-200,246,018.09
无形资产摊销-199,084,210.45-98,757,800.06
长期待摊费用摊销-6,342,789.25-3,338,275.55
处置固定资产、无形资产和其他长期资产的损失--427,415.37--33,873.75
固定资产报废损失-2,045,860.56-154,537.92
公允价值变动损失-149,331.32-2,953,441.37
财务费用-122,063,506.17-58,976,413.63
投资损失--13,020,046.98--3,223,803.03
递延所得税--40,411,704.85--19,184,322.67
其中:递延所得税资产减少--21,131,054.45--12,988,990.81
递延所得税负债增加--19,280,650.4--6,195,331.86
存货的减少-228,759,740.31-130,407,345.05
经营性应收项目的减少-583,885,319.81-497,940,981.39
经营性应付项目的增加--820,284,937.05--656,077,669.18
现金的期末余额-817,532,973.76-1,260,750,839.16
减:现金的期初余额-692,333,157.89-692,333,157.89
公告日期2025-04-262025-04-262024-10-292024-08-28
审计意见(境内)标准无保留意见
TOP↑